EP1545554A4 - Methods and compositions for treating diabetes mellitis - Google Patents

Methods and compositions for treating diabetes mellitis

Info

Publication number
EP1545554A4
EP1545554A4 EP02756627A EP02756627A EP1545554A4 EP 1545554 A4 EP1545554 A4 EP 1545554A4 EP 02756627 A EP02756627 A EP 02756627A EP 02756627 A EP02756627 A EP 02756627A EP 1545554 A4 EP1545554 A4 EP 1545554A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
treating diabetes
diabetes mellitis
mellitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02756627A
Other languages
German (de)
French (fr)
Other versions
EP1545554A1 (en
Inventor
Xiao Chen
Yun Sheng Li
Jing Li
Fang Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio University
Ohio State University
Original Assignee
Ohio University
Ohio State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio University, Ohio State University filed Critical Ohio University
Publication of EP1545554A1 publication Critical patent/EP1545554A1/en
Publication of EP1545554A4 publication Critical patent/EP1545554A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
EP02756627A 2002-07-24 2002-07-24 Methods and compositions for treating diabetes mellitis Withdrawn EP1545554A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/023523 WO2004009094A1 (en) 2002-07-24 2002-07-24 Methods and compositions for treating diabetes mellitis

Publications (2)

Publication Number Publication Date
EP1545554A1 EP1545554A1 (en) 2005-06-29
EP1545554A4 true EP1545554A4 (en) 2006-06-14

Family

ID=30769029

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02756627A Withdrawn EP1545554A4 (en) 2002-07-24 2002-07-24 Methods and compositions for treating diabetes mellitis

Country Status (6)

Country Link
EP (1) EP1545554A4 (en)
JP (1) JP2005538987A (en)
CN (1) CN1668311A (en)
AU (1) AU2002322623A1 (en)
CA (1) CA2496912A1 (en)
WO (1) WO2004009094A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357796B2 (en) 2004-01-23 2013-01-22 Ohio University PGG separation and purification
JP2006056850A (en) * 2004-08-23 2006-03-02 Suntory Ltd Lipase inhibitor
WO2006034468A2 (en) * 2004-09-23 2006-03-30 Ohio University Methods and compositions for treating hyperglycemic, hyperlipidemic, or hyperinsulinemic disorders
WO2009064082A1 (en) * 2007-11-13 2009-05-22 Igsbio Composition comprising galla rhois extract for prevention and treatment of obesity by means of autophagic mechanism
CN102482310B (en) 2009-10-29 2015-08-19 米兰集团 For the gallotannin compounds of lithographic plate coating composition
US20140128585A1 (en) * 2011-07-07 2014-05-08 Nagaoka Perfumery Co., Ltd. Fructose absorption inhibitor
RU2020118555A (en) * 2017-12-07 2022-01-13 Сайньюрекс Интернэшнл (Тайвань) Корп. IMPROVED METHODS OF ENRICHMENT FOR OBTAINING COMPOSITIONS OF TANNIC ACID
US11154531B2 (en) 2020-02-08 2021-10-26 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
KR20230004765A (en) 2020-04-23 2023-01-06 신유알엑스 인터내셔널 (타이완) 코포레이션 COMPOUNDS AND PHARMACEUTICAL USES THEREOF
CN111905029A (en) * 2020-08-26 2020-11-10 中国农业大学 Medicinal composition containing gentisic acid and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000025787A1 (en) * 1998-10-30 2000-05-11 Guilford Pharmaceuticals Inc. Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
JP2002080362A (en) * 2000-06-21 2002-03-19 Kao Corp Ppar-dependent gene transcription activator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2380299A1 (en) * 1977-02-09 1978-09-08 Gilbert Carraz Hypoglycaemic glucoside cpds. of gallic and ellagic acid - prepd. from pomegranate roots or from glucose and gallic acid chloride
JPH0759515B2 (en) * 1986-10-21 1995-06-28 株式会社ツムラ Aldo-reductase inhibitor
KR19980074710A (en) * 1997-03-21 1998-11-05 손경식 Cholesterol lowering pharmaceutical composition
DE60135760D1 (en) * 2000-08-01 2008-10-23 Oryza Oil & Fat Chem NIGHT CANDLE EXTRACTS AS INHIBITORS OF SUGAR ABSORPTION AND THEIR MANUFACTURING PROCESS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000025787A1 (en) * 1998-10-30 2000-05-11 Guilford Pharmaceuticals Inc. Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
JP2002080362A (en) * 2000-06-21 2002-03-19 Kao Corp Ppar-dependent gene transcription activator

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JIE ZHANG AND JIA-HE LI: "PARP and PARG as novel therapeutic targets", DRUGS OF THE FUTURE, vol. 27, no. 4, April 2002 (2002-04-01), pages 371 - 383, XP002378108 *
NONAKA ET AL.: "Tannins and Related Compounds. LVIII. Novel Gallotannins Possessing an alpha-Glucose Core from Nuphar japonicum DC", CHEM PHARM BULL, vol. 35, no. 8, 1987, pages 3127 - 3131, XP008084720 *
PATENT ABSTRACTS OF JAPAN vol. 2002, no. 07 3 July 2002 (2002-07-03) *
See also references of WO2004009094A1 *

Also Published As

Publication number Publication date
AU2002322623A1 (en) 2004-02-09
EP1545554A1 (en) 2005-06-29
WO2004009094A1 (en) 2004-01-29
JP2005538987A (en) 2005-12-22
CN1668311A (en) 2005-09-14
CA2496912A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
IL176259A0 (en) Compositions and methods for treating diabetes
EP1545578A4 (en) Compositions and methods for treating cardiovascular disease
AU2003287443A8 (en) Compositions and methods for pain reduction
AU2003268032A1 (en) Composition and methods for treatment and screening
AU2003212850A1 (en) Methods and compositions for treating cardiovascular disease
AU2003232044A8 (en) Composition and method for dermatological treatment
AU2003297573A8 (en) Compositions and methods for treating transplants
IL161073A0 (en) Composition and method for treating diabetes
EP1545554A4 (en) Methods and compositions for treating diabetes mellitis
EP1572085A4 (en) Methods and compositions for treating and diagnosing diabetes
EP1572085A3 (en) Methods and compositions for treating and diagnosing diabetes
IL166062A0 (en) Compositions and methods for therapeutic treatment
AU2003275433A1 (en) Compositions and methods for treating pain
EP1511506A4 (en) Compositions and methods for preventing, treating and diagnosing diabetes
AU2003299652A8 (en) Methods for treating diabetes
IL148924A0 (en) Compositions and methods for treating and preventing necrosis
IL163878A0 (en) Compositions and methods for treating mdma-inducedtoxicity
AU2003291461A8 (en) Compositions for diabetes treatment and prophylaxis
GB0203528D0 (en) Process and composition
AU2002350090A1 (en) Device and method for treating combination dependencies
AU2002953397A0 (en) Compositions and methods for treating aneurysm
GB0211889D0 (en) Composition and method
GB0210365D0 (en) Composition and method
GB0210497D0 (en) Composition and method
GB0229293D0 (en) Composition and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050224

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20060512

17Q First examination report despatched

Effective date: 20060921

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091223